logo

France Respiratory Devices Market Size (2024 - 2029)

The France Respiratory Devices Market is projected to experience growth driven by the increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease, tuberculosis, asthma, and pneumonia. Despite a decline in demand for certain devices like masks due to the easing of COVID-19 restrictions, the market is expected to expand due to new applications and studies on respiratory devices that enhance patient care. However, the high cost of these devices may pose a challenge to market growth.

Home Market Analysis Healthcare Research Medical Devices Research Medical Supplies Research Medical Consumables Research Respiratory Supplies Research France Respiratory Devices Market Market Size

Market Size of France Respiratory Devices Industry

France Respiratory Devices Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR (2024 - 2029) 6.50 %

Major Players

France Respiratory Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

France Respiratory Devices Market Analysis

The France Respiratory Devices Market is expected to register a CAGR of 6.5% during the forecast period(2024-2029).

  • Major respiratory devices such as masks, ventilators, nebulizers, CPAP, BiPAP, and oxygen concentrators were in great demand during the COVID-19 pandemic to prevent and manage infection in the country. However, with the easing of COVID-19 restrictions on wearing masks and the decline in COVID-19 cases, the demand for respiratory devices is anticipated to decrease. For instance, in March 2022, France lifted most COVID-19 restrictions, abolishing the need to wear face masks in most settings and allowing people who aren't vaccinated back into restaurants, sports arenas, and other venues. This lifted COVID-19 restrictions in the country decreases the demand for respiratory disposables like masks, which are expected to have an adverse impact on the market over the coming years.
  • The rise in the number of respiratory disease cases like chronic obstructive pulmonary disease (COPD), tuberculosis, asthma, and pneumonia remains the major driver of the industry. For instance, as per the report published by Plos One in January 2021, in France, there are 2.6 million people who have chronic obstructive pulmonary disease (COPD) in 2021, and by 2025, that number is expected to rise to 2.8 million. This shows the increasing prevalence of respiratory disease, which is expected to increase the demand for respiratory devices and likely propel the market over the forecast period.
  • Furthermore, the new studies on respiratory devices for expanding the applications are expected to drive market growth. For instance, as per the study report published by PLoS One in January 2022, the use of respiratory-connected devices has been emphasized as a crucial new tactic for enhancing patient care during a COPD exacerbation. Hence, the new studies on respiratory devices provide various new applications and likely increase the demand for respiratory devices and are expected to boost the growth of the market over the forecast period.
  • However, the high cost of various respiratory devices is expected to hinder market growth over the forecast period.

France Respiratory Devices Industry Segmentation

Respiratory devices include respiratory diagnostic and monitoring devices, therapeutic devices, and disposables for administering long-term artificial respiration.

The France respiratory devices market is segmented by type (diagnostic and monitoring devices (spirometers, sleep test devices, peak flow meters, pulse oximeters, capnographs, and other diagnostic and monitoring devices), therapeutic devices (CPAP devices, BiPAP devices, humidifiers, nebulizers, oxygen concentrators, ventilators, inhalers, and other therapeutic devices) and disposables (masks, breathing circuits, and other disposables)).

The report offers the value (in USD) for the above segments.

By Type
Diagnostic and Monitoring Devices
Spirometers
Sleep Test Devices
Peak Flow Meters
Pulse Oximeters
Capnographs
Other Diagnostic and Monitoring Devices
Therapeutic Devices
CPAP Devices
BiPAP Devices
Humidifiers
Nebulizers
Oxygen Concentrators
Ventilators
Inhalers
Other Therapeutic Devices
Disposables
Masks
Breathing Circuits
Other Disposables
Need A Different Region Or Segment?
Customize Now

France Respiratory Devices Market Size Summary

The France respiratory devices market is poised for growth, driven by the increasing prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and tuberculosis. The demand for respiratory devices like spirometers, inhalers, and nebulizers is expected to rise due to the high burden of these conditions, exacerbated by factors such as smoking. Despite the easing of COVID-19 restrictions leading to a decline in demand for certain devices like masks, the ongoing need for effective management and diagnosis of respiratory disorders continues to propel the market. Innovations and advancements in respiratory devices, including portable spirometers and connected devices, are further expected to enhance patient care and drive market expansion over the forecast period.

The market landscape is competitive, with key players such as Drägerwerk AG & Co. KGaA, Drive Devilbiss International, and Fisher & Paykel Healthcare Limited actively participating. Strategic partnerships and product developments, like ResMed's distribution of BIOSENCY's telemonitoring device, are indicative of the dynamic nature of the market. However, the high cost of respiratory devices poses a challenge to market growth. Nonetheless, the increasing demand for inhalers and other devices, driven by the need for effective treatment and management of respiratory conditions, is anticipated to sustain market growth in France through the forecast period.

Explore More

France Respiratory Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Respiratory Disorders

      2. 1.2.2 Technological Advancements

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Devices

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 2.1 By Type

      1. 2.1.1 Diagnostic and Monitoring Devices

        1. 2.1.1.1 Spirometers

        2. 2.1.1.2 Sleep Test Devices

        3. 2.1.1.3 Peak Flow Meters

        4. 2.1.1.4 Pulse Oximeters

        5. 2.1.1.5 Capnographs

        6. 2.1.1.6 Other Diagnostic and Monitoring Devices

      2. 2.1.2 Therapeutic Devices

        1. 2.1.2.1 CPAP Devices

        2. 2.1.2.2 BiPAP Devices

        3. 2.1.2.3 Humidifiers

        4. 2.1.2.4 Nebulizers

        5. 2.1.2.5 Oxygen Concentrators

        6. 2.1.2.6 Ventilators

        7. 2.1.2.7 Inhalers

        8. 2.1.2.8 Other Therapeutic Devices

      3. 2.1.3 Disposables

        1. 2.1.3.1 Masks

        2. 2.1.3.2 Breathing Circuits

        3. 2.1.3.3 Other Disposables

France Respiratory Devices Market Size FAQs

The France Respiratory Devices Market is projected to register a CAGR of 6.5% during the forecast period (2024-2029)

Fisher & Paykel Healthcare Limited, GE Healthcare, GSK plc, Medtronic plc and Drägerwerk AG & Co. KGaA are the major companies operating in the France Respiratory Devices Market.

France Respiratory Devices Market Report Snapshots

France Respiratory Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)